Seroprevalence and seroconversion for tickborne diseases in a high-risk population in the northeast United States

被引:90
作者
Hilton, E
DeVoti, J
Benach, JL
Halluska, ML
White, DJ
Paxton, H
Dumler, JS
机构
[1] Long Isl Jewish Med Ctr, N Shore Long Isl Jewish Hlth Syst, Div Clin Res, Albert Einstein Coll Med, New Hyde Park, NY 11042 USA
[2] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Dept Hlth, Stony Brook, NY 11794 USA
[4] Integrated Diagnost Inc, Baltimore, MD 21205 USA
[5] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S0002-9343(99)00046-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To determine the prevalence of serologic reactivity, the 1-year incidence of seroconversion, and the frequency of multiple infections, and their associations with symptoms in a group of volunteers at high risk for tick-borne infections in New York state. METHODS: We performed a seroepidemiologic study of Lyme borreliosis, 2 of the ehrlichioses, Rocky Mountain spotted fever, and babesiosis among 671 participants who lived or worked in a high-risk area (mainly in eastern Long Island, New York) for tick-borne diseases. Sera were collected in the winters of 1994 and 1995. Signs and symptoms of tick-borne disease were monitored monthly by mail and telephone. Lyme borreliosis serologies were done by enzyme-linked immunosorbent assay and Western blot. Rocky Mountain spotted fever serologies were initially screened using Dip-S-Ticks, followed by specific indirect immunofluorescence. Ehrlichiosis serologies were determined by epifluorescent microscopy, as were antibodies to Babesia microti. RESULTS: Of the 671 participants, 88 ( 13%) had antibodies to greater than or equal to 1 tick-borne organisms, including 34 (5% of the total) with antibodies to Borrelia burgdorferi. Twenty-seven participants had evidence of exposure to B. burgdorferi at baseline. Seven participants (1%) seroconverted during the course of the study, 5 of whom were symptomatic for Lyme borreliosis. Antibodies to spotted fever group rickettsiae were seen in 28 participants (4%), 22 of whom were positive at baseline and 6 of whom seroconverted during the observation period. None of the seropositive patients had any symptoms or signs of infection. Twenty-four participants (3%) had serologic evidence of exposure to Ehrlichia tall but one to Ehrlichia equi); 5 (0.7%) seroconverted during the observation period, including 3 subjects who were asymptomatic. Antibodies to B. microti were seen in 7 participants (1%), including one asymptomatic seroconversion during the year of observation. There was evidence of possible dual infection in 5 patients. CONCLUSION: In a high-risk population, there was evidence of exposure to 5 tick-borne pathogens; however, many infections were asymptomatic, and coinfections were rare. (C) 1999 by Excerpta Medica.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 34 条
[1]   SEROLOGICAL EVIDENCE FOR SIMULTANEOUS OCCURRENCES OF LYME-DISEASE AND BABESIOSIS [J].
BENACH, JL ;
COLEMAN, JL ;
HABICHT, GS ;
MACDONALD, A ;
GRUNWALDT, E ;
GIRON, JA .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (03) :473-477
[2]   CHANGING PATTERNS IN INCIDENCE OF ROCKY-MOUNTAIN SPOTTED-FEVER ON LONG-ISLAND (1971-1976) [J].
BENACH, JL ;
WHITE, DJ ;
BURGDORFER, W ;
KEELAN, T ;
GUIRGIS, S ;
ALTIERI, RH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (05) :380-387
[3]   Babesiosis [J].
Boustani, MR ;
Gelfand, JA .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (04) :611-614
[4]   IDENTIFICATION OF A GRANULOCYTOTROPIC EHRLICHIA SPECIES AS THE ETIOLOGIC AGENT OF HUMAN-DISEASE [J].
CHEN, SM ;
DUMLER, JS ;
BAKKEN, JS ;
WALKER, DH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (03) :589-595
[5]   NATIONAL SURVEILLANCE FOR ROCKY-MOUNTAIN-SPOTTED-FEVER, 1981-1992 - EPIDEMIOLOGIC SUMMARY AND EVALUATION OF RISK-FACTORS FOR FATAL OUTCOME [J].
DALTON, MJ ;
CLARKE, MJ ;
HOLMAN, RC ;
KREBS, JW ;
FISHBEIN, DB ;
OLSON, JG ;
CHILDS, JE .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (05) :405-413
[6]   A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden [J].
Dumler, JS ;
Dotevall, L ;
Gustafson, R ;
Granstrom, M .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) :720-722
[7]   SEROLOGIC CROSS-REACTIONS AMONG EHRLICHIA-EQUI, EHRLICHIA-PHAGOCYTOPHILA, AND HUMAN GRANULOCYTIC EHRLICHIA [J].
DUMLER, JS ;
ASANOVICH, KM ;
BAKKEN, JS ;
RICHTER, P ;
KIMSEY, R ;
MADIGAN, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1098-1103
[8]   HUMAN EHRLICHIOSIS IN ADULTS AFTER TICK EXPOSURE - DIAGNOSIS USING POLYMERASE CHAIN-REACTION [J].
EVERETT, ED ;
EVANS, KA ;
HENRY, RB ;
MCDONALD, G .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (09) :730-735
[9]   SEROSURVEY FOR HUMAN BABESIOSIS IN NEW-YORK [J].
FILSTEIN, MR ;
BENACH, JL ;
WHITE, DJ ;
BRODY, BA ;
GOLDMAN, WD ;
BAKAL, CW ;
SCHWARTZ, RS .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (04) :518-521
[10]   HUMAN EHRLICHIOSIS IN THE UNITED-STATES, 1985 TO 1990 [J].
FISHBEIN, DB ;
DAWSON, JE ;
ROBINSON, LE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (09) :736-743